Terms: = Breast cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572
34 results:
1. The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract] [Full Text] [Related]
2. Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy.
Yin G; Liu L; Yu T; Yu L; Feng M; Zhou C; Wang X; Teng G; Ma Z; Zhou W; Ye C; Zhang J; Ji C; Zhao L; Zhou P; Guo Y; Meng X; Fu Q; Zhang Q; Li L; Zhou F; Zheng C; Xiang Y; Guo M; Wang Y; Wang F; Huang S; Yu Z
Genome Med; 2024 Jan; 16(1):11. PubMed ID: 38217005
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
4. foxp1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
Wang L; Luo P; Yang Z; Zhong X; Ji C
PLoS One; 2023; 18(3):e0280794. PubMed ID: 36952469
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human breast cancer.
Yi J; Tan S; Zeng Y; Zou L; Zeng J; Zhang C; Liu L; Fan P
Sci Rep; 2022 May; 12(1):8896. PubMed ID: 35614183
[TBL] [Abstract] [Full Text] [Related]
6. Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer.
Chodary Khameneh S; Razi S; Shamdani S; Uzan G; Naserian S
Sci Rep; 2022 Feb; 12(1):2990. PubMed ID: 35194111
[TBL] [Abstract] [Full Text] [Related]
7. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.
Kusi M; Zand M; Lin LL; Chen M; Lopez A; Lin CL; Wang CM; Lucio ND; Kirma NB; Ruan J; Huang TH; Mitsuya K
Cell Rep; 2022 Jan; 38(2):110220. PubMed ID: 35021081
[TBL] [Abstract] [Full Text] [Related]
8. TET2 directs mammary luminal cell differentiation and endocrine response.
Kim MR; Wu MJ; Zhang Y; Yang JY; Chang CJ
Nat Commun; 2020 Sep; 11(1):4642. PubMed ID: 32934200
[TBL] [Abstract] [Full Text] [Related]
9. PRMT5 and foxp1 expression profile in invasive breast cancer patients undergoing neoadjuvant chemotherapy.
Su H; Liu Y; Zhang C; Yu T; Niu Y
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):142-145. PubMed ID: 32415941
[TBL] [Abstract] [Full Text] [Related]
10. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling.
Wei X; Li S; He J; Du H; Liu Y; Yu W; Hu H; Han L; Wang C; Li H; Shi X; Zhan M; Lu L; Yuan S; Sun L
Cell Commun Signal; 2019 Jun; 17(1):58. PubMed ID: 31170987
[TBL] [Abstract] [Full Text] [Related]
12. foxp1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
De Silva P; Garaud S; Solinas C; de Wind A; Van den Eyden G; Jose V; Gu-Trantien C; Migliori E; Boisson A; Naveaux C; Duvillier H; Craciun L; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
EBioMedicine; 2019 Jan; 39():226-238. PubMed ID: 30579865
[TBL] [Abstract] [Full Text] [Related]
13. Cytoplasmic foxp1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract] [Full Text] [Related]
14. PRMT5 Is a Critical Regulator of breast cancer Stem Cell Function via Histone Methylation and foxp1 Expression.
Chiang K; Zielinska AE; Shaaban AM; Sanchez-Bailon MP; Jarrold J; Clarke TL; Zhang J; Francis A; Jones LJ; Smith S; Barbash O; Guccione E; Farnie G; Smalley MJ; Davies CC
Cell Rep; 2017 Dec; 21(12):3498-3513. PubMed ID: 29262329
[TBL] [Abstract] [Full Text] [Related]
15. Deletion of 3p13-14 locus spanning foxp1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis.
Hieronymus H; Iaquinta PJ; Wongvipat J; Gopalan A; Murali R; Mao N; Carver BS; Sawyers CL
Nat Commun; 2017 Oct; 8(1):1081. PubMed ID: 29057879
[TBL] [Abstract] [Full Text] [Related]
16. foxp1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.
Oskay Halacli S
Cell Biol Int; 2017 Jan; 41(1):102-110. PubMed ID: 27859969
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of decreased foxp1 protein expression in various tumors: a systematic review and meta-analysis.
Xiao J; He B; Zou Y; Chen X; Lu X; Xie M; Li W; He S; You S; Chen Q
Sci Rep; 2016 Jul; 6():30437. PubMed ID: 27457567
[TBL] [Abstract] [Full Text] [Related]
18. A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes.
Cheng F; Zhao J; Fooksa M; Zhao Z
J Am Med Inform Assoc; 2016 Jul; 23(4):681-91. PubMed ID: 27026610
[TBL] [Abstract] [Full Text] [Related]
19. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
[TBL] [Abstract] [Full Text] [Related]
20. Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
Yan M; Shield-Artin K; Byrne D; Deb S; Waddell N; ; Haviv I; Fox SB
BMC Cancer; 2015 Jul; 15():506. PubMed ID: 26152113
[TBL] [Abstract] [Full Text] [Related]
[Next]
